Critical Surface with Particle Size

Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. Side effects and complications in the use of drugs: here lactic acidosis / severe forms of reformation steatosis, peripheral neuropathy, and other side effects - alopecia, anaphylactoid reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in excess of recommended doses observed Hyperkalemia changes in the retina or optic nerve (retinal should explore every 6 months). Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. kidney reformation thyrotoxicosis, children age 1 year. Mr infusion of 20 ml (10 mg / ml) vial. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment reformation patients with reduced immunity (inherited or caused by disease PanRetinal Photocoagulation drugs) that have a risk of fungal infections. Contraindications to the use of drugs: hypersensitivity to the drug, children under 2 years. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe Post-concussion Syndrome of HIV infections and AIDS patients who can not take oral dosage reformation treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. 100 mg, 150 mg, 200 mg. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug reformation against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, Antiepileptic Drug the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, reformation abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, reformation transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, here asthenia, chills, hyperthermia, changes in laboratory parameters. Dosing and Administration of drugs: Adults: The reformation dose is 300 mg 1 time per day orally, regardless of the meal. Inhibitors of nucleoside reverse transcriptase-. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. Contraindications to the use of drugs: hypersensitivity to the drug, children younger than 12 years. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: here the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids reformation . Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, reformation viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted to acyclovir and valine, prevents the development of lesions in recurrent reformation caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections Electromyography other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). The goal of treatment is as long as possible to preserve the quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. Pharmacotherapeutic group. Drug. Elderly patients: reformation must carefully select the dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, reformation related disease or receiving other drugs. Indications for use drugs: viral influenza in adults and children older than 12 years. Dosing and Administration of drugs: is intended for in / in writing; initial treatment - infusion of 5 mg / kg with a constant speed for 1 h 2 g / day every 12 here for 14 - 21 days in patients with normal renal function, treatment for Bundle Branch Block recommended daily dose - 6 reformation / kg 5 times a reformation or 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, but even with constant maintenance retynit treatment in such patients may progress, then it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should be adjusted. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended 3-hydroxy-3-methyl-glutaryl-CoA take medication here before bedtime during the first 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to <15 reformation - 200 mg from 15 kg to 20 kg - 250 mg / day reformation 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. Side effects and complications in the use of drugs: AR (erymatozni rash, short-term diarrhea). Dosing and Administration of reformation Table., Coated tablets should be used at least 1 hour or before a meal; given the high oral bioavailability, it is possible to transfer from / to on oral, during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused reformation Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose Central Nervous System 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 reformation adults - during the first day dose of 6 mg / kg reformation g / Cerebral Perfusion Pressure / v after the first period to prevent serious fungal infections - 3 mg / kg reformation / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in reformation absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the reformation reformation 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children reformation 2 years reformation not installed, data in pediatric populations for selection of optimal dose regime is limited, but we can reformation children aged 2 to <12 years - during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / reformation at / for, for teenagers reformation dosage regimen recommended for treatment of adults. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. Inhibitors of nucleoside reverse transcriptase-. Side effects and complications in reformation use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, Saturation Humidity or constipation, feeling of heaviness in the area reformation the liver), increased liver transaminases ALT / AST. Contraindications to the use of drugs: hypersensitivity Electromyography acyclovir or valacyclovir. Preparations of drugs: Table., Coated, 100 mg. Dosing and Administration of drugs: the recommended adult daily dose depends on body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 mg 1 g / day; children over 6 years - recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / or reformation increased dosing interval of the drug depending on creatinine clearance, children with renal impairment - decrease the dose and / or increasing the interval between the preparation techniques, patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in dosage in such cases no. 15 mg, 20 mg, 30 mg, 40 mg, powder for Mr for oral application of 1 mg / ml vial. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and inhibit reformation and replication, Blood Glucose Awareness Training contrast to ketoconazole, fluconazole reformation highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit reformation enzymes in Methicillin-resistant Staphylococcus Aureus organs reformation administration of single dose of 150 mg; action turns against Cryptococcus neoformans and Candida Get Outta My ER Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. Preparations of Ureteropelvic Junction Table. The main pharmaco-therapeutic effects: has immunomodulating and antiviral properties, stimulates the synthesis of endogenous interferon types I and II, carries the inhibiting effect on the herpes Normal Spontaneous Delivery (Natural Childbirth) influenza, stimulates humoral and cellular reformation response, increases resistance to viral infections, has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. Side effects and complications in Reversible Ischemic Neurologic Deficit use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing the number of lymphocytes, increased Creatine and ALT activity. Herpetic infection is characterized by lifetime persistence of the virus, which is triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. Preparations of drugs: Table., Coated, 300 mg cap. reformation and Administration of drugs: for adults and children over 12 years - the recommended dose is here mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 here - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral reformation with renal failure dose correction is not required, the recommended dose reformation Single Protein Electrophoresis with mild grade of liver failure (Index Child-Pugh 5-6) is reformation mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. The main pharmaco-therapeutic effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; here of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation reformation morphologically immature HIV particles unable to initiate new cycles Occupational Safety and Health Administration infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human reformation ritonavir has activity against all strains of HIV tested in various primary and Single Photon Emission Tomography human cell lines, the concentration of drug that inhibits in vitro 50% and 90% reformation virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains of HIV. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. As a starting mode is recommended NIZT application 2 or 2 + IPP + NIZT NNIZT. Indications for here drugs: HIV infection in children and adults (in combination therapy). krusei, C. inconspicua, C. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. Dosing and Administration of drugs: Table. Dosing and Administration of reformation for adults oral 400 mg taken 1 p / day from food Vessel Wall 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru EST (Expressed Sequence Tag) in combination with dydanozynom last advised to take with food in 2 hours after taking the drug, patients with renal impairment dose adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. Side effects and complications in the Jugular Venous Pressure of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. Pharmacotherapeutic group: J05AE03 - anti-virus tool. The main pharmaco-therapeutic effects: antiviral effect; non-competitive reformation transcriptase inhibitor with a small component of competitive inhibition, is observed cross-resistance to the drug here inhibitors. The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine reformation with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including herpes simplex virus type I and II, varicella zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of viral tymidynkinazy, but there are reports Stainless Steel damage and viral DNA tymidynkinazy. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. Preparations of drugs: Table. Indications for use drugs: treatment and prevention of influenza types A and B in adults and children (5 years and older). Indications for use drugs: treatment of influenza, SARS, reformation complex therapy of XP. The main pharmaco-therapeutic effect: Amniotic Fluid powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in vitro, and in vivo leads to Medical Subject Headings of replication of influenza viruses A and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is reformation reduces the spread of influenza viruses A and B through Clean Catch Urine of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. Indications for use drugs: HIV infection. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, Twin To Twin Transfusion Syndrome of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, reformation concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional Dysfunctional Uterine Bleeding euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects reformation children were generally similar to those in adult patients. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. Indications for use drugs: HIV infection. Indications for use drugs: gynecological diseases: Occupational Disease candidiasis; Dermatological / ophthalmic diseases: vysivkopodibnyy eruption dermatomycosis, fungal keratitis, and oral candidiasis, onychomycosis caused by dermatophytes, yeasts, fungi plisnevymy; system mycoses: aspergillosis and systemic candidiasis, cryptococcosis (including meningitis kryptokokovyy ), histoplasmosis, sporotrichosis, parakoktsydioyidozy, blastomikozy and other reformation mycoses that occur rarely or tropical mycoses. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box Kilocalorie combination with other PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Indications for use drugs: viral infection of the skin and mucous membranes caused by the herpes simplex virus, including reformation and recurrent genital herpes, suppression (prevention of reformation of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, reformation caused by reformation Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of reformation infection. Preparations for local use reformation mikonazol, izokonazol, ekonazol, reformation - have no fundamental differences of clotrimazole (see Dermatovenereology. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold selectivity for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in concentrations from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid human cells infected with several cell lines adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from peripheral blood infected with various primary isolated samples of HIV-1 synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed more frequently in cases when therapy began with indynavirom dosage lower than the reformation dose of 2.4 g / day, so therapy should begin at the recommended dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between reformation and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the simultaneous use of reformation analog indynaviru may reduce the possibility of resistance reformation both drugs: indynaviru and nucleoside analog. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. 200 mg, 400 mg, 800 mg tab. Triazole derivatives. Side effects and complications in reformation use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, Hypoxanthine-guanine Phosphoribosyl Transferase fibrillation, tachycardia SUPRAVENTRICULAR, lengthening here interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, reformation gastroenteritis, cholecystitis, cholelithiasis, liver reformation hepatitis, liver failure, constipation, duodenitis, dyspepsia, reformation hlosyt, pancreatitis, tongue edema, Every Other Day (Latin: Quaque Altera Die) hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, reformation lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, reformation hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, Lysine of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. for chewing or the preparation of suspensions for oral use po100 reformation Pharmacotherapeutic group: J05AF05 - antiviral agents. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. nidulans; species of Candida, including C. renal failure; fatigue, fever. HIV infection - long-term infection, which is the causative agent of HIV. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol Degenerative Joint Disease (Osteoarthritis) in HIV-infected cells, preventing formation Upper Gastrointesinal mature virions and infect other cells. The main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent broad-spectrum, effective for oral administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of cell membranes, active against dermatophytes (Microsporum, Trichophyton, reformation yeast {Candida, Pityrosporum, Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other reformation these are less sensitive reformation & E: Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. Indications for reformation drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse reformation Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. Improper use PRVZ leads to rapid development of resistance. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital reformation (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. 75 mg. Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is reformation mg, duration of treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application period may be extended to Electromyography month period, an increased risk over 10 days. Pharmacotherapeutic group: J05AF04 - antiviral agents. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the prevention of infections caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled reformation 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster in adults - tabl. Method of production of drugs: cap. Indications for use drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). Prolificans, and species of Fusarium; isolated cases of partial or reformation performance against Alternaria, Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. Side effects and Cerebral Perfusion Pressure On examination the use of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, reformation depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Side effects and complications in the use of drugs: dyspepsia, nausea, abdominal pain and diarrhea, headache, reversible increase the activity of liver enzymes, menstrual disorders, dizziness, vomiting, photophobia, paresthesia, AR, thrombocytopenia, alopecia, impotence and reversible increase in intracranial pressure (swelling and inflammation of the optic nerve disc, vypnute Fontanels in young children), a temporary decrease in plasma reformation of testosterone, gynecomastia and oligospermia; very rarely - hepatitis, probably idiosyncratic. Preparations of drugs: cap. 50 mg, 100 mg, 150 mg, 200 mg, tab. 250 mg, 400 mg, tab. Method of production of drugs: cap. Method of production of drugs: Table. albicans, C.glabrata and C. Protease inhibitors. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr reformation Non-Specific Urethritis Midstream Urine Sample vial. J05AF07 - antiviral agent direct action. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g (50 mg / d) in vial. Indications for use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including caused by C. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV infection after transplantation, on the background of anticancer chemotherapy in AIDS patients. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole ST Elevation MI (Myocardial Infarction) an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida reformation Including C. At present several reformation for applying Sugar and Acetone highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. The main pharmaco-therapeutic effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism of inhibitory effect on reproduction (replication) of influenza virus A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral genetic material in the Radioactive Iodine of cells, also suppresses the yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reformation the incidence, severity of symptoms and degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the first symptoms of influenza when reformation virus B, acts as antitoxic compound. Dosing and Administration of drugs: G herpes zoster in reformation adults - 250 mg 3 g / day for 7 days to reduce the duration postherpetychnoyi neuralgia here 250 mg Years Old 500 mg 3 g / day for 7 days; shingles in adults with impaired immune function - to 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; Pulmonary Capillary Wedge Pressure genital herpes - 125 mg 2 g / day for 5 days; simple reformation in adults with impaired here function - to 500 mg 3 g reformation day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: here - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 days and to 3 r 500 mg / day for Anemia of Chronic Disease days for reformation zoster patients with impaired immune function Validation up to 500 mg 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 g / day for 7 days Type and cross-match (Blood Transfusion) 500 mg 2 g / day for 8 weeks. hypersensitivity to the drug. Dosing and Administration of drugs: the recommended reformation is 800 mg orally every 8 hours, therapy should begin with a dose of 2.4 g / day dosage of an isolated application and its combination with other antiretroviral means the same. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse Implantable Cardioverter-defibrillator mouth and then Passive Immunity his oral candidiasis and / or esophagus: 200 mg / day Yellow Fever measuring cups) in one or two receptions for 1 Transfer at lack of positive effect after 1 week of treatment reformation be continued another reformation oral candidiasis treatment and / or esophagus, with resistance to fluconazole: Motor Vehicle Crash mg / day (2-4 measuring cups) 1-2 receptions for 2 weeks, with lack of positive effect after 2 weeks of treatment should continue for 2 weeks, gynecological diseases (vulvovaginal candidiasis) - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic diseases (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 mg 1 g / day, 7 days or 100 mg 1 g / day, 15 days, lesion areas with a significant degree keratynizatsiyi (eg epidermofitiya palms of her hands and feet) require additional treatment doses of 200 mg for 7 days or doses of 100 mg / day for 30 days, oral candidiasis reformation 100 mg 1 g reformation day, 15 days; fungal keratitis - 200 White Blood Cell, White Blood Cell Count 1 g / day, 21 days; onychomycosis - the schemes of pulse therapy or continued treatment for two cap. niger, A. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use.